Nitric oxide plays an important role in vascular function, helping regulate blood vessel relaxation and blood flow. These processes are particularly relevant to erectile function, where adequate blood flow is essential.
Liboost® is a specialised damiana leaf extract derived from Turnera diffusa, characterised by its flavonoid content. Research into this ingredient has explored several biological mechanisms associated with sexual function, including nitric oxide production, phosphodiesterase type 5 (PDE5) expression and aromatase activity.
Findings from laboratory studies provide insight into how Liboost® interacts with these biological pathways. While the results are promising from a research perspective, further clinical investigation is needed to establish whether these effects translate into measurable benefits in humans.
Product Profile
Liboost® is a botanical extract derived from the leaves of Turnera diffusa, commonly known as damiana. The plant has a history of traditional use in preparations associated with sexual health, and its naturally occurring flavonoids have attracted scientific interest for their potential biological activity.
The extract has been investigated using high-performance liquid chromatography (HPLC) and other analytical techniques to characterise its chemical composition. Research has identified a range of flavonoids and related compounds, including luteolin- and apigenin-derived glycosides.
These compounds are of interest because flavonoids can interact with biological pathways involved in vascular function and cellular signalling.
Research into Liboost® has focused on three areas:
-
Nitric oxide production: Investigating the extract's effect on nitric oxide levels in endothelial cells.
-
PDE5 expression: Examining its influence on a protein involved in regulating the signalling pathway associated with smooth muscle relaxation.
-
Aromatase activity: Evaluating its effect on an enzyme responsible for converting androgens into oestrogens.
Together, these investigations provide a broader picture of the ingredient's biological activity than nitric oxide research alone.
Product Advantages
Characterised Flavonoid Profile
Liboost® has been analysed using chromatographic techniques to identify and quantify its constituent compounds. This approach supports ingredient characterisation and provides a basis for investigating relationships between chemical composition and biological activity.
Investigated for Nitric Oxide Production
An in vitro study found that Liboost® significantly increased nitric oxide levels in human endothelial cells at a concentration of 10 µg/ml compared with untreated controls. The effect was not statistically significant at 40 µg/ml, indicating that the response differed between the concentrations tested.
Research into PDE5 Expression
A separate investigation examined the effect of Liboost® on PDE5 expression in a human cell model. The researchers reported a significant reduction under the experimental conditions.
PDE5 is involved in breaking down cyclic guanosine monophosphate (cGMP), a signalling molecule that contributes to smooth muscle relaxation. These findings provide a basis for further research into the extract's interaction with this pathway, although changes in PDE5 expression in cultured cells do not establish the same effect in human erectile tissue.
Investigated for Aromatase Activity
Research has also examined Liboost®'s effect on aromatase, an enzyme involved in the conversion of androgens into oestrogens. The study reported reduced aromatase activity at certain tested concentrations.
The physiological significance of this finding, including whether it produces meaningful hormonal effects in humans, remains to be established.
Preliminary Cell Compatibility Findings
In the reported cell-based experiments, Liboost® did not significantly reduce cell viability at the concentrations used for the respective assays.
These results provide preliminary information about cellular compatibility under laboratory conditions. They should not be interpreted as proof of safety at all doses or following long-term use in humans.
Research: Understanding Nitric Oxide and Erectile Function
Nitric oxide is a signalling molecule that helps regulate blood vessel tone. It contributes to vasodilation, the process by which blood vessels relax and allow blood to flow more freely.
In men, nitric oxide is central to the physiological processes involved in achieving an erection. Its activity promotes the production of cGMP, which helps relax smooth muscle within erectile tissue and facilitates increased blood flow.
The enzyme endothelial nitric oxide synthase (eNOS) is one source of nitric oxide in endothelial cells. Consequently, research into ingredients that influence endothelial nitric oxide production is relevant to the investigation of vascular mechanisms associated with erectile function.
However, erectile function involves several interconnected processes, including nerve signalling, vascular health and smooth muscle activity. An increase in nitric oxide in cultured endothelial cells is therefore an important laboratory observation, but it cannot independently demonstrate improved erectile function in humans.
Study Findings
1. Flavonoid Characterisation
Research published in 2026 examined the chemical composition of Liboost® using advanced analytical techniques, including high-performance liquid chromatography coupled with diode-array detection and high-resolution mass spectrometry (HPLC-DAD-HRMS).
The researchers identified 49 compounds, predominantly flavonoids and related phenolic compounds. The analysis included luteolin- and apigenin-derived glycosides, flavonols, methoxyflavones, flavanones and coumaroyl derivatives.
The study reported a total quantified flavonoid content of 15.9 mg/g.
This detailed characterisation helps establish the chemical profile of the tested extract and provides a foundation for investigating which constituents may contribute to its observed biological effects.
2. Nitric Oxide Production in Endothelial Cells
An earlier study by Almodóvar and colleagues investigated the effect of Liboost® on nitric oxide release in human umbilical vein endothelial cells (HUVECs).
The researchers first characterised the extract's flavonoids using HPLC. They then assessed cell viability and measured nitric oxide production following treatment with the extract at concentrations of 10 and 40 µg/ml.
Nitric oxide levels were evaluated by measuring nitrite accumulation in the cell culture medium using the Griess reaction.
The findings showed that treatment with Liboost® at 10 µg/ml produced a statistically significant increase in nitric oxide levels compared with the control. The researchers proposed that the effect could be associated with activation of eNOS by flavonoids present in the damiana extract.
The findings demonstrate an effect in a laboratory cell model. The proposed involvement of eNOS is a potential explanation for the observed response rather than definitive proof of the precise mechanism.
3. Effects on PDE5 Expression
The 2026 study also investigated the extract's effect on PDE5 expression in a human dermal fibroblast cell model.
The researchers reported a significant reduction in PDE5 expression following treatment with Liboost® at the tested concentrations.
PDE5 plays a role in regulating cGMP levels by breaking down this signalling molecule. In erectile physiology, the nitric oxide–cGMP pathway contributes to the relaxation of smooth muscle within erectile tissue.
The observed reduction in PDE5 expression is therefore relevant to research into this pathway. However, the experiment measured PDE5 expression in cultured cells rather than demonstrating inhibition of PDE5 activity in human erectile tissue.
This distinction is important when interpreting the findings and considering their potential practical applications.
4. Effects on Aromatase Activity
The 2026 investigation also examined whether Liboost® influenced aromatase activity in a human liver-derived cell model.
The researchers reported reduced aromatase activity at certain tested concentrations, with statistically significant reductions at 0.25 and 0.5 mg/ml.
Aromatase is responsible for converting androgens, including testosterone, into oestrogens. Although the enzyme is relevant to hormonal regulation, the observed laboratory effect does not establish that Liboost® increases testosterone levels or produces a clinically meaningful hormonal change in humans.
Further research would be needed to determine the physiological relevance of this finding.
A Multi-Pathway Approach to Sexual Health Research
One notable aspect of the research into Liboost® is its investigation of several biological pathways rather than focusing exclusively on nitric oxide production.
The nitric oxide–cGMP pathway is involved in vascular signalling and smooth muscle relaxation. PDE5 regulates cGMP breakdown, while aromatase participates in hormone metabolism.
Investigating these mechanisms together provides a more comprehensive understanding of the extract's potential biological activity.
Separate research on damiana extracts and related botanical preparations has also explored sexual behaviour and nitric oxide-related mechanisms in preclinical models. These findings provide background for further investigation, but results from other extracts, animal studies or multi-ingredient formulations cannot automatically be attributed to Liboost®.
The available evidence supports continued investigation of Liboost® as a botanical ingredient of interest in sexual health research. It does not yet establish clinical efficacy for erectile dysfunction or other sexual health conditions.
Manufacturing and Quality Control
The characterisation of botanical ingredients is an important part of evaluating their quality and consistency.
In the published 2026 study, Liboost® was analysed using HPLC-DAD-HRMS to identify and quantify its major constituents. This approach enabled the researchers to develop a more detailed understanding of the extract's chemical composition.
The study described Liboost® as a commercial hydroalcoholic extract of Turnera diffusa, with the manufacturer declaring standardisation to more than 1.5% total flavonoids under the Liboonoides® designation.
Analytical characterisation supports research into the relationship between the composition of a botanical extract and its biological activity. However, specific manufacturing certifications, production standards and supply-chain claims should be confirmed through the supplier's technical documentation before publication.
Conclusion
Liboost® is a flavonoid-characterised damiana leaf extract that has been investigated for its interaction with biological pathways associated with sexual function.
Research has reported increased nitric oxide production in human endothelial cells at a specific tested concentration, alongside findings relating to PDE5 expression and aromatase activity in separate cell-based experiments.
These findings provide a scientific basis for further investigation into the extract's potential applications in men's health. They also highlight the importance of studying botanical ingredients through both chemical characterisation and functional testing.
Nevertheless, the evidence discussed here is primarily based on laboratory research. Further clinical trials in humans are required to determine whether the observed effects translate into meaningful health benefits, establish appropriate dosages and assess safety during use.
Liboost® therefore represents an ingredient of scientific interest, with its potential applications requiring further clinical validation.
About Liboost®
Liboost® is a damiana leaf extract derived from Turnera diffusa. Its flavonoid composition and biological activity have been investigated through analytical chemistry and laboratory-based studies, with research focusing on nitric oxide production, PDE5 expression and aromatase activity.
For technical specifications, supporting research and ingredient availability, please contact your Liboost® supplier or representative.
References
1. Almodóvar P, Salamanca A, Prodanov M, Muñoz-Santos D, González-Hedström D, Inarejos-García AM. “Liboost® induces the release of nitric oxide in endothelial cells in vitro.” Research report supplied for this article. Full publication details should be verified against the original document.
2. Benito-Vázquez I, Morán-Valero MI, Díez-Municio M, Mena-García A. “Flavonoid Composition and Molecular Basis of the Potential Sexual-Enhancing Properties of a Turnera diffusa Extract (Liboost®).” Pharmaceuticals. 2026;19(4):597. DOI: 10.3390/ph19040597.
Liboost®